SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

USO is trending due to escalating geopolitical tensions in the Middle East, specifically following reports of US-Israeli strikes on Iran, which is fueling intense community debate about potential oil supply disruptions, particularly through the Strait of Hormuz. Investors are sharply divided between anticipating a significant oil price spike and expecting a 'sell the news' reversal.

Codatta

XNY (Codatta) is drawing significant attention for its strong performance and resilience, often showing green metrics even when the broader crypto market faces pullbacks. The community is actively discussing its potential for further breakouts and new highs, driven by its utility in powering AI and decentralized science data projects, alongside recent exchange listings.

ProShares Trust - ProShares Ultra Gold 2x Shares

ProShares Ultra Gold

UGL is trending as escalating geopolitical uncertainties and concerns over ongoing fiat currency debasement spur significant safe-haven demand, with the community actively discussing gold's strong upward momentum and the broader precious metals rally.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund is surging as escalating Middle East tensions, including strikes on oil infrastructure and disruptions to the Strait of Hormuz, fuel community expectations of significant oil price spikes and a massive upward move for the sector.

The centrifuge token model powers centrifuge, providing the framework needed to run the platform without reliance on a single point of failure, including the centrifuge team or Company, and to accelerate its utility. To accomplish this, centrifuge leverages the cryptoeconomic primitives of a native token called the centrifuge token (cfg), a nominated-proof-of-stake consensus algorithm that employs centrifuge to stake value, rewards for centrifuge adoption, and an on-chain governance mechanism that empowers centrifuge holders to guide the development of centrifuge.

Centrifuge

Centrifuge is trending following the launch of the world's first licensed S&P 500 Index Fund Token, a development hailed by the community as a monumental step for institutional adoption and a significant advancement in tokenizing real-world assets.

Wheaton Precious Metals Corp. is a precious metals streaming company with the quality portfolio of long-life, low-cost assets. Its business model offers investors commodity price leverage and exploration upside but with a much lower risk profile than a traditional mining company. It operates through the following business segments: Gold, Silver, Palladium, Cobalt, and Other. Wheaton was founded by Peter Derek Barnes on December 17, 2004 and is headquartered in Vancouver, Canada.

Wheaton Precious Metals Corp

Wheaton Precious Metals is gaining attention amid soaring gold prices reaching all-time highs and silver breaking multi-decade resistance, amplifying interest in its asset-light streaming model. The community is discussing recent strong earnings, a robust balance sheet, and a series of analyst target increases, though some express skepticism about its short-term price movements relative to the broader precious metals sector.

OR Royalties, Inc. engages in the acquisition, mining, and exploration of precious metals, streams, and other royalties. It holds interests in the Canadian Malartic mine. The company was founded on April 29, 2014 and is headquartered in Montreal, Canada.

OR Royalties Inc.

Osisko Gold Royalties Ltd

Osisko Gold Royalties is attracting significant community interest following its joint acquisition of a major gold stream on SolGold's Cascabel project and the emergence of activist investor Elliott Management as a large stakeholder. This news, combined with robust preliminary Q2 results showcasing record cash margins, reinforces bullish sentiment for the stable gold royalty player.

Direxion Shares ETF Trust - Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

GUSH is trending amid heightened speculation surrounding escalating Middle East geopolitical tensions and their potential impact on global oil supply routes, with the community actively discussing a significant upward move for oil and gas exploration and production.

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc

Aardvark Therapeutics is facing intense scrutiny and negative sentiment after voluntarily pausing its Phase 3 HERO trial for ARD-101 due to reversible cardiac safety signals observed in high-dose studies. The community is expressing significant concern about the drug's future and the company's prospects in the competitive Prader-Willi Syndrome treatment landscape.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is a focal point of intense market and social media discussion following significant military action against Iran, including the reported death of its Supreme Leader, as investors and community members weigh the geopolitical implications and ongoing controversies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TriSalus Life Sciences (TLSI) to Release Earnings on Thursday

TriSalus Life Sciences (NASDAQ:TLSI) will be releasing its Q4 2025 earnings after the market closes on Thursday, March 5. (View Earnings Report at...

TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (TriSalus or the Company), an oncology-focused medical technology company advancing novel drug delivery technologies alongside standard-of-care therapies...

TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (TriSalus or the Company), an oncology focused medical technology company advancing novel drug delivery technologies alongside standard-of-care therapies...

TriSalus Life Sciences Proposes Public Offering

TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors

TriSalus Life Sciences (NASDAQ:TLSI) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut shares of TriSalus Life Sciences from a "hold" rating to a "sell" rating in a research note on Sunday...

TriSalus Life Sciences (NASDAQ:TLSI) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of TriSalus Life Sciences from a "sell" rating to a "hold" rating in a research note on Saturday...

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives Consensus Rating of "Hold" from Analysts

Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI - Get Free Report) have received a consensus recommendation of "Hold" from the five research firms that are currently covering the stock...

Wall Street Zen cut shares of TriSalus Life Sciences from a "hold" rating to a "sell" rating in a research report on Saturday...

TriSalus Life Sciences, Inc. (TLSI) Upgraded to Buy: Here's What You Should Know

TriSalus Life Sciences, Inc. (TLSI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.

TriSalus Life Sciences Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Current Price	$5.06
Prev Close	$5.38
Open	$5.31
Dividend Yield	0.00%
50-Day Moving Average	$5.69
Beta	0.45
Avg. Volume	138,642.25
PE Ratio	-2.51

52-Week High	$7.95
52-Week Low	$3.42
Market Capitalization	$302.65M
EPS (Annual)	-$1.31
Price to Book	-9.45
Revenue Per Employee	$267,554.54

TLSI
TriSalus Life Sciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TLSI News

TLSITriSalus Life Sciences Inc